Mechanism of action
Glutathione is a tripeptide composed of glutamate, cysteine, and glycine. It functions as the body's master antioxidant and detoxifying agent through multiple mechanisms.
Antioxidant activity
Glutathione directly scavenges reactive oxygen species (ROS) including hydroxyl radicals and singlet oxygen. It serves as a cofactor for glutathione peroxidase, which reduces hydrogen peroxide and lipid peroxides to water and alcohols, protecting cellular membranes and proteins from oxidative damage.
Detoxification and conjugation
Glutathione conjugates electrophilic compounds and xenobiotics via glutathione S-transferase enzymes. This is critical in acetaminophen toxicity: the toxic metabolite N-acetyl-p-benzoquinone imine (NAPQI) is normally conjugated by hepatic glutathione stores. When glutathione is depleted (in overdose), NAPQI accumulates and causes centrilobular hepatic necrosis. Exogenous glutathione or its precursors (N-acetylcysteine) replenish hepatic stores and prevent liver damage.
Reduction of disulfide bonds
Glutathione reduces disulfide bonds in mucus glycoproteins, decreasing mucus viscosity. This mucolytic property is exploited in respiratory conditions with thick secretions.
Cellular protection
Glutathione maintains the intracellular redox state, regenerates other antioxidants (vitamins C and E), and protects against chemotherapy-induced oxidative stress in normal tissues.
- Glutathione is a tripeptide (γ-glutamyl-cysteinyl-glycine) and the body's primary intracellular antioxidant.
- In acetaminophen overdose, glutathione conjugates the toxic metabolite NAPQI; when depleted, NAPQI causes centrilobular hepatic necrosis.
- Oral glutathione has poor bioavailability (<5%) due to rapid hydrolysis by γ-glutamyltransferase in the gut and liver.
- N-acetylcysteine is preferred over glutathione clinically because it provides cysteine (rate-limiting for GSH synthesis) and has better pharmacokinetics.
- Glutathione does not effectively cross the blood-brain barrier in its intact form.
- Inhaled glutathione can cause bronchospasm, especially in patients with asthma or reactive airway disease.
- Glutathione may theoretically reduce chemotherapy efficacy by protecting cancer cells from oxidative damage.
- The GSH:GSSG (reduced-to-oxidized glutathione) ratio is a key marker of cellular redox status and oxidative stress.
Indications
Clinical use of exogenous glutathione is limited by poor oral bioavailability and rapid metabolism. N-acetylcysteine, a glutathione precursor, is more commonly used clinically.
Acetaminophen (paracetamol) toxicity
Glutathione depletion is the central mechanism of acetaminophen hepatotoxicity. While N-acetylcysteine is the standard antidote (providing cysteine for glutathione synthesis), intravenous glutathione has been studied as an alternative, particularly when N-acetylcysteine is unavailable or not tolerated.
Chemotherapy-induced toxicity
Glutathione is investigated as a cytoprotective agent to reduce cisplatin-induced nephrotoxicity and neurotoxicity, and to mitigate oxidative damage from anthracyclines. Evidence for efficacy is mixed, and concerns exist about potential reduction of chemotherapy effectiveness.
Non-alcoholic fatty liver disease (NAFLD)
Oxidative stress contributes to NAFLD progression. Glutathione supplementation is studied to reduce hepatic inflammation and fibrosis, though clinical evidence remains preliminary.
Respiratory conditions
Inhaled glutathione is used off-label as a mucolytic in cystic fibrosis, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis, though nebulized N-acetylcysteine is more established.
Other investigational uses
Glutathione is explored for Parkinson disease (oxidative stress hypothesis), male infertility (sperm oxidative damage), and skin lightening (inhibits tyrosinase), but robust clinical evidence is lacking for these indications.
Pharmacokinetics
Absorption
Oral glutathione has extremely poor bioavailability (less than 5%) because it is rapidly hydrolyzed by intestinal and hepatic γ-glutamyltransferase into constituent amino acids before reaching systemic circulation. Liposomal and sublingual formulations claim improved absorption but evidence is limited.
Distribution
Glutathione is highly concentrated intracellularly, particularly in the liver, kidney, lung, and erythrocytes. It does not cross the blood-brain barrier effectively in its intact form. Intravenous administration achieves higher plasma levels but tissue penetration remains limited.
Metabolism
Glutathione is cleaved by γ-glutamyltransferase on cell membranes into glutamate and cysteinylglycine. Cysteinylglycine is further hydrolyzed to cysteine and glycine. These amino acids are taken up by cells and used to resynthesize intracellular glutathione via the γ-glutamyl cycle.
Elimination
Glutathione and its metabolites are primarily excreted renally. The plasma half-life of exogenous glutathione is short (minutes), reflecting rapid tissue uptake and enzymatic degradation.
Clinical implications
Because of poor oral bioavailability and rapid degradation, intravenous administration is required for acute toxicological indications. N-acetylcysteine is preferred clinically because it provides cysteine (the rate-limiting amino acid for glutathione synthesis) and has better pharmacokinetic properties.
Adverse effects
Exogenous glutathione is generally well tolerated, but adverse effects can occur, particularly with intravenous or inhaled administration.
Hypersensitivity reactions
Intravenous glutathione can cause allergic reactions ranging from rash and pruritus to anaphylaxis. Patients with sulfur sensitivity may be at increased risk.
Respiratory effects
Inhaled glutathione can trigger bronchospasm, cough, and dyspnea, especially in patients with asthma or reactive airway disease. The sulfur content may irritate airways.
Gastrointestinal effects
Oral glutathione may cause nausea, abdominal cramping, bloating, and diarrhea, although these are typically mild.
Dermatologic effects
Skin rash and flushing have been reported with intravenous administration.
Theoretical concerns
Cancer growth: High glutathione levels may protect cancer cells from chemotherapy and radiation by neutralizing oxidative damage. This is a theoretical concern when using glutathione as a cytoprotective agent during cancer treatment.
Immune modulation: Glutathione affects T-cell function and cytokine production; the clinical significance of exogenous supplementation on immune responses is unclear.
Contamination risk
Non-pharmaceutical glutathione supplements may contain contaminants or have variable potency, as dietary supplements are not rigorously regulated.
Contraindications and warnings
Hypersensitivity
Glutathione is contraindicated in patients with known hypersensitivity to glutathione or any formulation component. Use caution in patients with sulfur or sulfite sensitivity.
Asthma and reactive airway disease
Inhaled glutathione should be avoided or used with extreme caution in patients with asthma, as it can precipitate bronchospasm. Bronchodilator pretreatment may be necessary.
Pregnancy and lactation
Glutathione is likely safe in pregnancy as an endogenous compound, but data on exogenous supplementation are limited. It is probably compatible with breastfeeding given its presence in human milk and rapid metabolism.
Pediatric use
Safety and efficacy in children are not well established. N-acetylcysteine is preferred for acetaminophen toxicity in pediatric patients.
Renal and hepatic impairment
No specific dose adjustments are established, but caution is warranted as these organs are critical for glutathione metabolism and excretion.
Cancer patients
The use of glutathione during active cancer treatment is controversial. While it may protect normal tissues from chemotherapy toxicity, it could theoretically protect cancer cells as well, potentially reducing treatment efficacy. Oncologists should be consulted before use.
Drug interactions
Chemotherapeutic agents
Glutathione may reduce the cytotoxic effects of alkylating agents (cyclophosphamide, cisplatin) and anthracyclines (doxorubicin) by neutralizing reactive oxygen species and conjugating electrophilic metabolites. This could theoretically decrease chemotherapy efficacy, though clinical evidence is conflicting. Some studies suggest glutathione may protect normal tissues without compromising tumor response.
Alcohol
Chronic alcohol consumption depletes hepatic glutathione stores, increasing susceptibility to acetaminophen toxicity and oxidative stress. Glutathione or N-acetylcysteine may have enhanced importance in this population.
Acetaminophen (paracetamol)
Glutathione directly conjugates the toxic metabolite NAPQI in acetaminophen overdose. While this is therapeutic, the interaction highlights the importance of maintaining adequate glutathione stores or providing precursors (N-acetylcysteine) early in overdose management.
Nitroglycerin
Glutathione is required for the bioactivation of nitroglycerin to nitric oxide. Glutathione depletion contributes to nitrate tolerance. Supplementation may theoretically restore nitrate responsiveness.
Warfarin
No direct interaction is established, but glutathione's antioxidant effects could theoretically affect vitamin K metabolism. Monitor INR if combining.
Immunosuppressants
Glutathione modulates T-cell function and may theoretically alter the effects of immunosuppressive drugs, though clinical significance is unknown.
Clinical pearls
- N-acetylcysteine is preferred over glutathione in acetaminophen toxicity because it has better bioavailability, longer half-life, and extensive clinical evidence. N-acetylcysteine provides cysteine, the rate-limiting substrate for intracellular glutathione synthesis.
- Glutathione does not cross the blood-brain barrier in its intact form, limiting its utility in neurological oxidative stress conditions. However, N-acetylcysteine does penetrate the CNS and can increase brain glutathione.
- Oral glutathione supplementation is largely ineffective due to rapid enzymatic degradation in the GI tract. Claims about liposomal formulations improving bioavailability lack robust evidence. Eating glutathione-rich foods (cruciferous vegetables, whey protein) or taking N-acetylcysteine is more rational for boosting endogenous levels.
- The glutathione-to-oxidized-glutathione (GSH:GSSG) ratio is a key marker of cellular redox status. A low ratio indicates oxidative stress and is implicated in aging, neurodegenerative diseases, and metabolic disorders.
- Glutathione depletion is a final common pathway in many toxicological emergencies beyond acetaminophen, including carbon tetrachloride, arsenic, and heavy metal poisoning. Maintaining adequate stores is critical for hepatic detoxification.
- Inhaled glutathione for cystic fibrosis is supported by small studies showing improved pulmonary function and reduced oxidative stress markers, but large randomized trials are lacking. It is not FDA-approved for this indication.
- Skin lightening claims for glutathione are based on its inhibition of tyrosinase (the rate-limiting enzyme in melanin synthesis) and antioxidant effects. Evidence for efficacy is weak, and safety of high-dose supplementation for cosmetic purposes is uncertain.
- Measuring plasma glutathione is of limited clinical utility because it does not reflect intracellular stores, where glutathione exerts its effects. Tissue biopsy or specialized assays are needed for accurate assessment.
Practice questions
1. A 19-year-old woman is brought to the emergency department 6 hours after ingesting 18 grams of acetaminophen in a suicide attempt. She is lethargic but arousable. Laboratory studies show AST 95 U/L, ALT 110 U/L, and an acetaminophen level of 180 mcg/mL. Which of the following best describes the mechanism by which treatment will prevent hepatotoxicity in this patient?
2. A 45-year-old man with metastatic colon cancer receiving FOLFOX chemotherapy asks about taking glutathione supplements to reduce side effects. His oncologist is concerned about a potential interaction. Which of the following best explains this concern?
3. A clinical trial investigates oral glutathione supplementation (500 mg daily) for non-alcoholic fatty liver disease. After 12 weeks, plasma glutathione levels are measured and show no significant increase compared to placebo. Which of the following best explains this finding?
Frequently asked questions
How does glutathione work?
Glutathione works by directly scavenging reactive oxygen species and serving as a cofactor for glutathione peroxidase to neutralize hydrogen peroxide and lipid peroxides. It conjugates toxic electrophilic compounds via glutathione S-transferase enzymes, which is critical in detoxifying substances like the acetaminophen metabolite NAPQI. Glutathione also reduces disulfide bonds in proteins and mucus, maintains cellular redox balance, and regenerates other antioxidants like vitamins C and E.
What are the side effects of glutathione?
Glutathione is generally well tolerated, but side effects can occur, particularly with intravenous or inhaled administration. These include hypersensitivity reactions ranging from rash to anaphylaxis, bronchospasm and cough with inhalation (especially in asthmatics), gastrointestinal upset (nausea, cramping, diarrhea), and skin flushing. Theoretical concerns include potential protection of cancer cells from chemotherapy and immune system modulation, though clinical significance is uncertain.
Is glutathione effective for liver detox?
Glutathione is essential for hepatic detoxification, particularly in conjugating toxic metabolites like NAPQI in acetaminophen overdose. However, oral glutathione supplements have poor bioavailability (less than 5%) because they are rapidly broken down before reaching the liver. For acute toxicity, intravenous glutathione or N-acetylcysteine is required. There is preliminary evidence for glutathione in non-alcoholic fatty liver disease, but robust clinical data are lacking. Maintaining endogenous glutathione through adequate protein intake and N-acetylcysteine supplementation is more effective than oral glutathione.
Glutathione vs N-acetylcysteine — what is the difference?
N-acetylcysteine (NAC) is a precursor that provides cysteine, the rate-limiting amino acid for glutathione synthesis inside cells. NAC has much better oral bioavailability, longer half-life, and ability to cross the blood-brain barrier compared to glutathione itself, which is rapidly degraded in the gut and bloodstream. For clinical purposes like acetaminophen overdose, NAC is strongly preferred because it effectively replenishes intracellular glutathione stores. Glutathione supplementation is limited by poor absorption and rapid metabolism.
Can you take glutathione during chemotherapy?
Taking glutathione during chemotherapy is controversial and should only be done under oncologist supervision. While glutathione may protect normal tissues from chemotherapy-induced oxidative damage (especially with cisplatin and anthracyclines), there is theoretical concern that it could also protect cancer cells, potentially reducing treatment efficacy. Some studies suggest tissue protection without compromising tumor response, but evidence is mixed. The decision depends on the specific chemotherapy regimen, cancer type, and individual risk-benefit assessment by the treating oncologist.
Conditions it is used for
Related drugs
Sources and further reading
DailyMed (FDA labels)StatPearls (NCBI Bookshelf)MedlinePlusWHO ATC/DDD index: V03AB32
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.